Newsletter
Oracle funded research being reviewed for major international Cancer Research journal
Oracle project title: Sensitizing p53 mutant head and neck cancer to oncolytic virotherapy by targeting the endoplasmic…
HPV in head and neck cancer
80% of people will get HPV Over 80% of people will get HPV (human papilloma virus) at…
New project – increasing sensitivity to radio- and chemotherapy in adenoid cystic carcinoma
Oracle to support much needed research in rare form of head and neck cancer Arturo Sala (left),…
Oracle-funded study improves treatment prospects for cancer patients
Read the ICR’s latest blog post about the success of our recent Oracle-funded study into combining radiotherapies…
- « Previous
- 1
- …
- 4
- 5
- 6